193 related articles for article (PubMed ID: 31486520)
21. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
22. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
23. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Gu J; Chan T; Zhang J; Leung AY; Kwong YL; Khong PL
AJR Am J Roentgenol; 2011 Sep; 197(3):W384-91. PubMed ID: 21862763
[TBL] [Abstract][Full Text] [Related]
24. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
25. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
26. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
Abdulqadhr G; Molin D; Aström G; Suurküla M; Johansson L; Hagberg H; Ahlström H
Acta Radiol; 2011 Mar; 52(2):173-80. PubMed ID: 21498346
[TBL] [Abstract][Full Text] [Related]
27. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of
Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
[TBL] [Abstract][Full Text] [Related]
29. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
Regacini R; Puchnick A; Luisi FAV; Lederman HM
Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
Grueneisen J; Sawicki LM; Schaarschmidt BM; Suntharalingam S; von der Ropp S; Wetter A; Ruhlmann V; Quick HH; Forsting M; Umutlu L
PLoS One; 2016; 11(6):e0157880. PubMed ID: 27327617
[TBL] [Abstract][Full Text] [Related]
31. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma.
Zanoni L; Mattana F; Calabrò D; Paccagnella A; Broccoli A; Nanni C; Fanti S
Eur J Radiol; 2021 Aug; 141():109793. PubMed ID: 34148014
[TBL] [Abstract][Full Text] [Related]
32. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
Miles A; Evans RE; Halligan S; Beare S; Bridgewater J; Goh V; Janes SM; Navani N; Oliver A; Morton A; Morris S; Rockall A; Taylor SA;
J Med Imaging Radiat Oncol; 2020 Aug; 64(4):537-545. PubMed ID: 32410378
[TBL] [Abstract][Full Text] [Related]
33. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging of malignant lymphoma.
Vermoolen MA; Kersten MJ; Fijnheer R; van Leeuwen MS; Kwee TC; Nievelstein RA
Expert Rev Hematol; 2011 Apr; 4(2):161-71. PubMed ID: 21495926
[TBL] [Abstract][Full Text] [Related]
35. Whole-body diffusion-weighted MRI for staging lymphoma at 3.0T: comparative study with MR imaging at 1.5T.
Azzedine B; Kahina MB; Dimitri P; Christophe P; Alain D; Claude M
Clin Imaging; 2015; 39(1):104-9. PubMed ID: 25108666
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
38. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
[TBL] [Abstract][Full Text] [Related]
39. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
[TBL] [Abstract][Full Text] [Related]
40. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
